Publications by authors named "Laura Demopoulos"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

21

Total Likes

153

Extended Reach

5,823,260

Social Features

55
M
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease.
Matthew M Hsieh, Melissa Bonner, Francis John Pierciey, Naoya Uchida, James Rottman, Laura Demopoulos

Blood Adv· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction.
John J Lepore, Eric Olson, Laura Demopoulos, Thomas Haws, Zixing Fang

JACC Heart Fail· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease.
Eric Olson, Laura Demopoulos, Thomas F Haws, Erding Hu, Zixing Fang

Vasc Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pericardial effusion coincident with sirolimus therapy: a review of Wyeth's safety database.
George H Steele, Anthony B Adamkovic, Laura A Demopoulos, Linda C Rothrock, Maureen E Caulfield

Transplantation· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18.
Aaron D Kugelmass, Saihari Sadanandan, Nasser Lakkis, Peter M Dibattiste, Debbie H Robertson, Laura A Demopoulos

Crit Pathw Cardiol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination angiotensin receptor blocker/hydrochlorothiazide as initial therapy in the treatment of patients with severe hypertension.
Christina M Salerno, Laura Demopoulos, Robin Mukherjee, Alan H Gradman

J Clin Hypertens (Greenwich)· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes.
Richard G Bach, Christopher P Cannon, William S Weintraub, Peter M DiBattiste, Laura A Demopoulos

Ann Intern Med· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.
Jonathan C Fox, Kellie Leight, Santosh C Sutradhar, Laura A Demopoulos, Gilbert W Gleim

J Clin Hypertens (Greenwich)· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy).
C Michael Gibson, Kanwar P Singh, Sabina A Murphy, Peter M DiBattiste, Laura A Demopoulos

Am J Cardiol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy.
Howard C Herrmann, Sabina A Murphy, Peter M Dibattiste, Paul T Delucca, Laura A Demopoulos

Crit Pathw Cardiol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial.
Peter A McCullough, C Michael Gibson, Peter M Dibattiste, Laura A Demopoulos, Sabina A Murphy

J Interv Cardiol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Marc S Sabatine, David A Morrow, Robert P Giugliano, Sabina A Murphy, Laura A Demopoulos

Circulation· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy.
Stephen D Wiviott, Christopher P Cannon, David A Morrow, Sabina A Murphy, C Michael Gibson, Laura A Demopoulos

Circulation· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial.
Mitchell J Ross, Howard C Herrmann, David J Moliterno, James C Blankenship, Laura Demopoulos

J Am Coll Cardiol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction.
Graham C Wong, Daniel Frisch, Sabina A Murphy, Marc S Sabatine, Rupal Pai, Laura A Demopoulos

Am J Cardiol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy).
Duane S Pinto, David P Lorenz, Sabina A Murphy, Susan J Marble, Peter M DiBattiste, Laura A Demopoulos

Am J Cardiol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.
David A Morrow, James A de Lemos, Marc S Sabatine, Sabina A Murphy, Laura A Demopoulos

J Am Coll Cardiol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of an early invasive management strategy in women with acute coronary syndromes.
Ruchira Glaser, Howard C Herrmann, Sabina A Murphy, Laura A Demopoulos, Peter M DiBattiste

JAMA· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy.
Marc S Sabatine, David A Morrow, Christopher P Cannon, Sabina A Murphy, Laura A Demopoulos

J Am Coll Cardiol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction.
Elizabeth M Mahoney, Claudine T Jurkovitz, Haitao Chu, Edmund R Becker, Steven Culler, Laura A Demopoulos

JAMA· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes.
Sorin J Brener, Sabina A Murphy, C Michael Gibson, Peter M DiBattiste, Laura A Demopoulos

Am J Cardiol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes.
Neal S Kleiman, Nasser Lakkis, Christopher P Cannon, Sabina A Murphy, Peter M DiBattiste, Laura A Demopoulos

J Am Coll Cardiol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study.
David J Moliterno, Steven J Yakubov, Peter M DiBattiste, Howard C Herrmann, Gregg W Stone, Laura A Demopoulos

Lancet· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction.
Graham C Wong, David A Morrow, Sabina Murphy, Nicole Kraimer, Rupal Pai, Laura A Demopoulos

Circulation· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis